NEKTAR THERAPEUTICS Quarterly Return On Equity in % from Q3 2011 to Q3 2024

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Nektar Therapeutics quarterly/annual Return On Equity history and growth rate from Q3 2011 to Q3 2024.
  • Nektar Therapeutics Return On Equity for the quarter ending September 30, 2024 was -174 %, a 43% decline year-over-year.
  • Nektar Therapeutics annual Return On Equity for 2023 was -152 %, a 90% decline from 2022.
  • Nektar Therapeutics annual Return On Equity for 2022 was -79.8 %, a 28.8% decline from 2021.
  • Nektar Therapeutics annual Return On Equity for 2021 was -62 %, a 67.4% decline from 2020.
Return On Equity, Quarterly (%)
Return On Equity, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Start Date End Date
Q3 2024 -174 -52.4 -43% Jul 1, 2024 Sep 30, 2024
Q2 2024 -143 -41.7 -41.3% Apr 1, 2024 Jun 30, 2024
Q1 2024 -115 -2.32 -2.07% Jan 1, 2024 Mar 31, 2024
Q4 2023 -152 -71.8 -90% Oct 1, 2023 Dec 31, 2023
Q3 2023 -122 -37.7 -44.8% Jul 1, 2023 Sep 30, 2023
Q2 2023 -101 -18.5 -22.4% Apr 1, 2023 Jun 30, 2023
Q1 2023 -112 -46.6 -71% Jan 1, 2023 Mar 31, 2023
Q4 2022 -79.8 -17.8 -28.8% Oct 1, 2022 Dec 31, 2022
Q3 2022 -84.2 -31.7 -60.5% Jul 1, 2022 Sep 30, 2022
Q2 2022 -82.4 -36.7 -80.2% Apr 1, 2022 Jun 30, 2022
Q1 2022 -65.6 -27.5 -72.2% Jan 1, 2022 Mar 31, 2022
Q4 2021 -62 -25 -67.4% Oct 1, 2021 Dec 31, 2021
Q3 2021 -52.5 -18.2 -53.1% Jul 1, 2021 Sep 30, 2021
Q2 2021 -45.7 -14.2 -45% Apr 1, 2021 Jun 30, 2021
Q1 2021 -38.1 -6.13 -19.2% Jan 1, 2021 Mar 31, 2021
Q4 2020 -37 -8.06 -27.8% Oct 1, 2020 Dec 31, 2020
Q3 2020 -34.3 -7.59 -28.4% Jul 1, 2020 Sep 30, 2020
Q2 2020 -31.5 -6.2 -24.5% Apr 1, 2020 Jun 30, 2020
Q1 2020 -32 -69.6 -185% Jan 1, 2020 Mar 31, 2020
Q4 2019 -29 -79.2 -158% Oct 1, 2019 Dec 31, 2019
Q3 2019 -26.7 -105 -134% Jul 1, 2019 Sep 30, 2019
Q2 2019 -25.3 -198 -115% Apr 1, 2019 Jun 30, 2019
Q1 2019 37.6 +258 Jan 1, 2019 Mar 31, 2019
Q4 2018 50.2 +226 Oct 1, 2018 Dec 31, 2018
Q3 2018 78.6 +269 Jul 1, 2018 Sep 30, 2018
Q2 2018 173 +1.4K Apr 1, 2018 Jun 30, 2018
Q1 2018 -220 +2.85K +92.8% Jan 1, 2018 Mar 31, 2018
Q4 2017 -176 -3.37K -106% Oct 1, 2017 Dec 31, 2017
Q3 2017 -191 -846 -129% Jul 1, 2017 Sep 30, 2017
Q2 2017 -1.22K +7.54K +86% Apr 1, 2017 Jun 30, 2017
Q1 2017 -3.07K -2.4K -359% Jan 1, 2017 Mar 31, 2017
Q4 2016 3.19K +3.4K Oct 1, 2016 Dec 31, 2016
Q3 2016 656 +811 Jul 1, 2016 Sep 30, 2016
Q2 2016 -8.76K -8.77K -70627% Apr 1, 2016 Jun 30, 2016
Q1 2016 -670 -753 -905% Jan 1, 2016 Mar 31, 2016
Q4 2015 -206 +356 +63.4% Oct 1, 2015 Dec 31, 2015
Q3 2015 -155 -409 -161% Jul 1, 2015 Sep 30, 2015
Q2 2015 12.4 -296 -96% Apr 1, 2015 Jun 30, 2015
Q1 2015 83.2 -238 -74.1% Jan 1, 2015 Mar 31, 2015
Q4 2014 -562 -915 -259% Oct 1, 2014 Dec 31, 2014
Q3 2014 254 -1.19K -82.4% Jul 1, 2014 Sep 30, 2014
Q2 2014 309 +1.09K Apr 1, 2014 Jun 30, 2014
Q1 2014 322 +595 Jan 1, 2014 Mar 31, 2014
Q4 2013 354 +511 Oct 1, 2013 Dec 31, 2013
Q3 2013 1.44K +1.55K Jul 1, 2013 Sep 30, 2013
Q2 2013 -784 -708 -935% Apr 1, 2013 Jun 30, 2013
Q1 2013 -273 -207 -314% Jan 1, 2013 Mar 31, 2013
Q4 2012 -157 -102 -182% Oct 1, 2012 Dec 31, 2012
Q3 2012 -106 -50.7 -90.8% Jul 1, 2012 Sep 30, 2012
Q2 2012 -75.7 Apr 1, 2012 Jun 30, 2012
Q1 2012 -66 Jan 1, 2012 Mar 31, 2012
Q4 2011 -55.8 Oct 1, 2011 Dec 31, 2011
Q3 2011 -55.8 Jul 1, 2011 Sep 30, 2011
* An asterisk sign (*) next to the value indicates that the value is likely invalid.